Cilacar TC 12.5mg Tablet

About

Cilacar TC 12.5mg is a potent triple-combination antihypertensive medication formulated for patients requiring comprehensive blood pressure control, particularly those with resistant hypertension. It combines cilnidipine, a unique L/N-type calcium channel blocker that induces vasodilation; telmisartan, an angiotensin receptor blocker (ARB) that effectively blocks the vasoconstrictive and aldosterone-secreting effects of angiotensin II; and chlorthalidone, a long-acting thiazide-like diuretic that enhances the excretion of sodium and water, thereby reducing plasma volume. This multi-modal approach targets distinct mechanisms involved in blood pressure regulation, providing robust and sustained antihypertensive efficacy, reducing cardiovascular morbidity and mortality, and optimizing outcomes in complex hypertensive cases.

Uses

• Treatment of essential hypertension.
• Management of resistant hypertension.
• When blood pressure is not adequately controlled by dual therapy.
• To reduce the risk of major cardiovascular events.

Directions For Use

Take this tablet once daily, preferably at the same time each day, with or without food. Swallow whole with water.

Benefits

• Provides powerful triple-action blood pressure control.
• Highly effective for resistant or difficult-to-treat hypertension.
• Significantly reduces overall cardiovascular risk.
• Offers comprehensive management by targeting multiple pathways.
• Convenient once-daily dosing.
• Helps prevent stroke, heart attack, and kidney damage.

Side Effects

• Dizziness
• Headache
• Fatigue
• Peripheral edema
• Hypotension
• Electrolyte imbalance (e.g., hypokalemia)
• Nausea
• Diarrhea
• Muscle cramps
• Increased uric acid levels
• Cough (less common than ACE inhibitors)
• Orthostatic hypotension

Safety Measures

• Alcohol - Alcohol can potentiate the hypotensive effects, increasing the risk of dizziness and lightheadedness. Avoid or limit consumption.
• Pregnancy - Contraindicated during pregnancy, especially in the second and third trimesters, due to significant risks of fetal injury or death.
• Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and potentially harm the infant.
• Liver - Use with caution in patients with severe hepatic impairment, as telmisartan and cilnidipine are metabolized by the liver.
• Kidney - Contraindicated in severe renal impairment or anuria. Use with caution and monitor kidney function closely in moderate impairment.
• Lung - Generally safe for lung conditions, but monitor for any unusual respiratory symptoms, especially with diuretic use.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.